DK3297611T3 - Farmaceutiske sammensætninger af levetiracetam med langvarig frigivelse - Google Patents
Farmaceutiske sammensætninger af levetiracetam med langvarig frigivelse Download PDFInfo
- Publication number
- DK3297611T3 DK3297611T3 DK16728462.9T DK16728462T DK3297611T3 DK 3297611 T3 DK3297611 T3 DK 3297611T3 DK 16728462 T DK16728462 T DK 16728462T DK 3297611 T3 DK3297611 T3 DK 3297611T3
- Authority
- DK
- Denmark
- Prior art keywords
- levetiracetam
- long
- pharmaceutical compositions
- term release
- release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562165812P | 2015-05-22 | 2015-05-22 | |
| PCT/US2016/033567 WO2016191288A1 (en) | 2015-05-22 | 2016-05-20 | Extended release pharmaceutical compositions of levetiracetam |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3297611T3 true DK3297611T3 (da) | 2019-09-02 |
Family
ID=61223552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16728462.9T DK3297611T3 (da) | 2015-05-22 | 2016-05-20 | Farmaceutiske sammensætninger af levetiracetam med langvarig frigivelse |
Country Status (4)
| Country | Link |
|---|---|
| EP (2) | EP3590506A1 (da) |
| DK (1) | DK3297611T3 (da) |
| ES (1) | ES2747993T3 (da) |
| MA (1) | MA50634A (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023192686A1 (en) * | 2022-04-01 | 2023-10-05 | Li shi jiang | Methods for preventing or slowing the progression of cognitive decline or impairment in subjects displaying normal cognitive performance |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20050083971A (ko) | 2002-11-22 | 2005-08-26 | 더 존스 홉킨스 유니버시티 | 인지능 손상의 치료를 위한 표적 |
| EP2682481A3 (en) | 2005-08-03 | 2014-09-17 | The Johns-Hopkins University | Methods for characterizing and treating cognitive impairment in aging and disease |
| US20080014271A1 (en) * | 2006-07-13 | 2008-01-17 | Ucb, S.A. | Novel pharmaceutical compositions comprising levetiracetam |
| WO2008062446A2 (en) * | 2006-09-14 | 2008-05-29 | Alembic Limited | An extended release composition of levetiracetam, which exhibits no adverse food effect |
| CN102227217A (zh) * | 2008-10-16 | 2011-10-26 | 约翰斯.霍普金斯大学 | 改善认知功能的方法和组合物 |
| KR20120055313A (ko) * | 2010-11-23 | 2012-05-31 | 주식회사 바이오파마티스 | 레베티라세탐 또는 이의 약학적으로 허용되는 염을 포함하는 용출 안정성이 개선된 서방형 약학 조성물 및 이의 제조방법 |
| DE102011103270A1 (de) * | 2011-05-26 | 2012-11-29 | Stada Arzneimittel Ag | Pulverförmige Mischung zur Herstellung von Levetiracetam-haltigen Tabletten |
| DK2968220T3 (da) * | 2013-03-15 | 2021-06-14 | Agenebio Inc | Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion |
-
2016
- 2016-05-20 EP EP19175798.8A patent/EP3590506A1/en active Pending
- 2016-05-20 MA MA050634A patent/MA50634A/fr unknown
- 2016-05-20 EP EP16728462.9A patent/EP3297611B1/en active Active
- 2016-05-20 DK DK16728462.9T patent/DK3297611T3/da active
- 2016-05-20 ES ES16728462T patent/ES2747993T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3297611B1 (en) | 2019-07-03 |
| ES2747993T3 (es) | 2020-03-12 |
| MA50634A (fr) | 2021-04-28 |
| ES2747993T8 (es) | 2021-03-30 |
| EP3590506A1 (en) | 2020-01-08 |
| EP3297611A1 (en) | 2018-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3283107T3 (da) | Sammensætninger omfattende en kombination af ipilimumab og nivolumab | |
| DK3303317T3 (da) | Fremgangsmåder og sammensætninger til inhibering af interaktionen af menin med MLL-proteiner | |
| DK3509581T3 (da) | Formuleringer af (r)-2-amino-3-phenylpropylcarbamat | |
| DK3294720T3 (da) | Fremgangsmåde til fremstilling af terpinolenepoxid | |
| DK3102555T3 (da) | Sammensætninger af forbindelser og anvendelser deraf | |
| DK3393655T3 (da) | Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme | |
| DK2968221T3 (da) | Farmaceutisk sammensætning af s-ketaminhydrochlorid | |
| DK3144001T3 (da) | Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf | |
| DK3416996T3 (da) | Hærdelig sammensætning | |
| DK3079669T3 (da) | Sammensætninger med forsinket frigivelse af linaclotid | |
| DK3370949T3 (da) | Sammensætning af tætningsmiddel | |
| DK3328867T3 (da) | Krystallinsk form af fri base af lorlatinib | |
| IL287520A (en) | Levetiracetam extended-release pharmaceutical preparations | |
| DK3319609T3 (da) | Sammensætninger og fremgangsmåder til anvendelse af antibakterielle lægemiddelkombinationer | |
| DK3280408T3 (da) | Fremgangsmåde til fremstilling af dicycloplatin | |
| DK3368044T3 (da) | Behandling af hepatisk steatose-relateret oligo-ovulation | |
| DK3275452T3 (da) | Farmaceutisk sammensætning med silibinin | |
| DK3278801T3 (da) | Farmaceutisk sammensætning indeholdende mirabegron | |
| DK3227325T3 (da) | Sammensætninger med selektive hæmmere af il-6-trans-signalering | |
| DK3297619T3 (da) | Terapeutiske anvendelser af L-4-chlorkynurenin | |
| DK3331498T3 (da) | Nasalsammensætning | |
| DK3418273T3 (da) | Derivater af flavagliner | |
| DK2910535T3 (da) | Sammensætning til anvendelse af ekspanderet perlit | |
| DK3678644T3 (da) | Formuleringer af copanlisib | |
| DK3310331T3 (da) | Injicerbare farmaceutiske formuleringer af lefamulin |